April 1989
Volume 30, Issue 4
Free
Articles  |   April 1989
In vitro inhibition of lens epithelial cell growth by continuous wave Nd:YAG laser.
Author Affiliations
  • K Miyake
    Shohzankai Medical Foundation, Miyake Eye Hospital, Nagoya, Japan.
  • S Iwata
    Shohzankai Medical Foundation, Miyake Eye Hospital, Nagoya, Japan.
  • F Ando
    Shohzankai Medical Foundation, Miyake Eye Hospital, Nagoya, Japan.
  • N Daikuzono
    Shohzankai Medical Foundation, Miyake Eye Hospital, Nagoya, Japan.
  • J L Federman
    Shohzankai Medical Foundation, Miyake Eye Hospital, Nagoya, Japan.
Investigative Ophthalmology & Visual Science April 1989, Vol.30, 714-716. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K Miyake, S Iwata, F Ando, N Daikuzono, J L Federman; In vitro inhibition of lens epithelial cell growth by continuous wave Nd:YAG laser.. Invest. Ophthalmol. Vis. Sci. 1989;30(4):714-716.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Bovine lens epithelial cells were suspended in MEM medium and subjected to continuous wave, low power, pulsed neodymium:yttrium-aluminum-garnet (Nd:YAG) laser irradiation. The temperature of each suspension was maintained at 36 degrees C. Laser applications ranged from 1 to 10 watts and from 100 to 2000 seconds, but the total dose to each of the epithelial cell suspension was 2000 J. Six to thirty-nine percent of the cells were dead immediately after irradiation. Surviving cells, cultured for 15 days, showed decreased attachment and failed to grow. These preliminary results suggest that the Nd:YAG laser may be used during cataract surgery to prevent subsequent lens epithelial cell proliferation and the resulting vision reduction and glare.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×